CO6420374A2 - Efectos anti-perdida de hueso y pérdida de anti-adherimiento de una composición oral - Google Patents
Efectos anti-perdida de hueso y pérdida de anti-adherimiento de una composición oralInfo
- Publication number
- CO6420374A2 CO6420374A2 CO11114807A CO11114807A CO6420374A2 CO 6420374 A2 CO6420374 A2 CO 6420374A2 CO 11114807 A CO11114807 A CO 11114807A CO 11114807 A CO11114807 A CO 11114807A CO 6420374 A2 CO6420374 A2 CO 6420374A2
- Authority
- CO
- Colombia
- Prior art keywords
- loss
- test compound
- adhering
- bone
- effects
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 210000000988 bone and bone Anatomy 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102100027995 Collagenase 3 Human genes 0.000 abstract 1
- 108050005238 Collagenase 3 Proteins 0.000 abstract 1
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 abstract 1
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 abstract 1
- 230000033228 biological regulation Effects 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 201000001245 periodontitis Diseases 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56955—Bacteria involved in periodontal diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16568509P | 2009-04-01 | 2009-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6420374A2 true CO6420374A2 (es) | 2012-04-16 |
Family
ID=42328354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO11114807A CO6420374A2 (es) | 2009-04-01 | 2011-09-06 | Efectos anti-perdida de hueso y pérdida de anti-adherimiento de una composición oral |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8637266B2 (enExample) |
| EP (1) | EP2414838B1 (enExample) |
| JP (1) | JP5330596B2 (enExample) |
| CN (1) | CN102365550B (enExample) |
| AR (1) | AR076177A1 (enExample) |
| AU (1) | AU2010232590B2 (enExample) |
| BR (1) | BRPI1013185A2 (enExample) |
| CA (1) | CA2757317C (enExample) |
| CO (1) | CO6420374A2 (enExample) |
| DK (1) | DK2414838T3 (enExample) |
| ES (1) | ES2432864T3 (enExample) |
| MX (1) | MX2011008438A (enExample) |
| MY (1) | MY158406A (enExample) |
| PL (1) | PL2414838T3 (enExample) |
| RU (1) | RU2524629C2 (enExample) |
| SG (1) | SG173487A1 (enExample) |
| TW (1) | TWI405565B (enExample) |
| WO (1) | WO2010115031A1 (enExample) |
| ZA (1) | ZA201106054B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101745067B1 (ko) * | 2014-12-31 | 2017-06-12 | 서울대학교산학협력단 | 치주질환 예측 시스템 및 이를 이용한 치주질환 예측 방법 |
| KR102098624B1 (ko) * | 2019-09-20 | 2020-04-08 | 서울대학교산학협력단 | 타액 mmp-9 및 il-8를 이용한 치주염 예측 시스템 및 이를 이용한 치주염 예측 방법 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3538230A (en) | 1966-12-05 | 1970-11-03 | Lever Brothers Ltd | Oral compositions containing silica xerogels as cleaning and polishing agents |
| US4358437A (en) | 1978-11-29 | 1982-11-09 | Beecham Group Limited | Compositions |
| US5032386A (en) | 1988-12-29 | 1991-07-16 | Colgate-Palmolive Company | Antiplaque antibacterial oral composition |
| US5288480A (en) | 1987-01-30 | 1994-02-22 | Colgate-Palmolive Co. | Antiplaque antibacterial oral composition |
| US4894220A (en) | 1987-01-30 | 1990-01-16 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
| GB9117140D0 (en) | 1991-08-08 | 1991-09-25 | Unilever Plc | Treatment of periodontitis |
| DE4226043A1 (de) | 1992-08-06 | 1994-02-10 | Haarmann & Reimer Gmbh | Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen |
| US5756361A (en) * | 1992-12-17 | 1998-05-26 | Metra Biosystems, Inc. | Screening method for periodontal disease |
| CA2176237A1 (en) | 1993-11-10 | 1995-05-18 | Richard P. Darveau | Treatment of bacterially-induced inflammatory diseases |
| FI98961C (fi) * | 1994-08-26 | 1997-09-10 | Medix Biochemica Ab Oy | Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi |
| US5578295A (en) | 1995-04-28 | 1996-11-26 | The Procter & Gamble Company | Oral care compositions comprising certain substituted diphenyl ethers |
| EP0935454B1 (de) | 1996-06-12 | 2001-08-22 | Cognis Deutschland GmbH | Kosmetische und/oder pharmazeutische zubereitungen |
| US5998487A (en) * | 1998-04-08 | 1999-12-07 | Colgate-Palmolive Company | Anti-inflammatory and antibacterial benzyl phenol agents and their use in oral compositions |
| JP3763075B2 (ja) * | 1998-04-24 | 2006-04-05 | サンスター株式会社 | 歯周病の予防又は治療用の食品組成物、口腔用組成物及び医薬組成物 |
| FR2794457B1 (fr) | 1999-06-01 | 2001-08-10 | Oreal | Derives carbonates de retinol, procede de preparation et utilisations |
| US6165447A (en) * | 1999-06-15 | 2000-12-26 | Colgate-Palmolive Company | Synergistic antibacterial combination |
| WO2001048481A1 (en) | 1999-12-03 | 2001-07-05 | Baxter International Inc. | Pyrogenicity test for use with automated immunoassay systems |
| GB0001704D0 (en) | 2000-01-25 | 2000-03-15 | Glaxo Group Ltd | Protein |
| WO2001078652A2 (en) | 2000-04-14 | 2001-10-25 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| US7329489B2 (en) | 2000-04-14 | 2008-02-12 | Matabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| US6500409B1 (en) | 2000-05-10 | 2002-12-31 | Colgate Palmolive Company | Synergistic antiplaque/antigingivitis oral composition |
| DE10059584A1 (de) | 2000-11-30 | 2002-06-06 | Beiersdorf Ag | Kosmetische oder dermatologische getränkte Tücher |
| DOP2002000332A (es) * | 2001-02-14 | 2002-08-30 | Warner Lambert Co | Inhibidores de piridina de metaloproteinasas de la matriz |
| AU2003249531A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Azaisoquinoline derivatives as matrix metalloproteinase inhibitors |
| US7005225B2 (en) | 2002-11-12 | 2006-02-28 | Samsung Electronics Company | Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications |
| TW200902047A (en) | 2003-02-14 | 2009-01-16 | Combinatorx Inc | Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| GB2401865A (en) | 2003-05-22 | 2004-11-24 | Givaudan Sa | Antibacterial and antifungal glycerol monocarbonates |
| WO2005039504A2 (en) | 2003-10-24 | 2005-05-06 | Eisai Co., Ltd. | Compounds and methods for treating toll-like receptor 2-related diseases and conditions |
| US20070212686A1 (en) | 2003-12-03 | 2007-09-13 | Whitehead Institute For Biomedical Research | Use Of T-Cadherin As A Target |
| FI20040572A0 (fi) * | 2004-04-23 | 2004-04-23 | Ctt Cancer Targeting Tech Oy | Matriisi-metalloproteinaasin aktiviteetin inhibiittorit |
| JP4662043B2 (ja) * | 2004-09-09 | 2011-03-30 | 国立大学法人東京農工大学 | 歯周病発症の評価システム |
| CN101111288A (zh) * | 2004-12-02 | 2008-01-23 | 高露洁-棕榄公司 | 含酚类化合物和抗氧化剂维生素和维生素衍生物的口腔护理组合物 |
| US20060141421A1 (en) | 2004-12-28 | 2006-06-29 | Kimberly-Clark Worldwide, Inc. | System and method for detecting substances related to oral health |
| WO2006074450A2 (en) | 2005-01-07 | 2006-07-13 | President And Fellows Of Harvard College | Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases |
| JP5024506B2 (ja) * | 2005-03-25 | 2012-09-12 | ライオン株式会社 | 歯周組織破壊の抑制・改善剤及び口腔用組成物 |
| RU2431845C2 (ru) | 2006-01-10 | 2011-10-20 | Колгейт-Палмолив Компани | Способы модулирования рецепторов клеточных поверхностей для предотвращения или снижения воспаления |
| US20080161394A1 (en) | 2006-11-23 | 2008-07-03 | Jean-Yves Fouron | Cosmetic composition comprising at least one volatile carbonic acid ester |
| WO2008093072A2 (en) | 2007-01-29 | 2008-08-07 | Paul Webb | Topical composition against contact dermatitis due to water |
| US8333981B2 (en) | 2007-10-09 | 2012-12-18 | Humco Holding Group, Inc. | Antifungal treatment of nails |
| TWI481870B (zh) * | 2009-04-01 | 2015-04-21 | Colgate Palmolive Co | 用於軟組織疾病診斷及作為用於口腔保健干預的標靶之蛋白質生物標記 |
-
2010
- 2010-03-31 TW TW099109773A patent/TWI405565B/zh not_active IP Right Cessation
- 2010-03-31 AR ARP100101094A patent/AR076177A1/es unknown
- 2010-04-01 JP JP2012503715A patent/JP5330596B2/ja not_active Expired - Fee Related
- 2010-04-01 WO PCT/US2010/029670 patent/WO2010115031A1/en not_active Ceased
- 2010-04-01 EP EP10712854.8A patent/EP2414838B1/en not_active Revoked
- 2010-04-01 DK DK10712854.8T patent/DK2414838T3/da active
- 2010-04-01 CN CN201080015649.0A patent/CN102365550B/zh not_active Expired - Fee Related
- 2010-04-01 ES ES10712854T patent/ES2432864T3/es active Active
- 2010-04-01 AU AU2010232590A patent/AU2010232590B2/en not_active Ceased
- 2010-04-01 RU RU2011144028/15A patent/RU2524629C2/ru not_active IP Right Cessation
- 2010-04-01 BR BRPI1013185A patent/BRPI1013185A2/pt not_active IP Right Cessation
- 2010-04-01 MX MX2011008438A patent/MX2011008438A/es active IP Right Grant
- 2010-04-01 CA CA2757317A patent/CA2757317C/en not_active Expired - Fee Related
- 2010-04-01 PL PL10712854T patent/PL2414838T3/pl unknown
- 2010-04-01 US US13/262,027 patent/US8637266B2/en active Active
- 2010-04-01 MY MYPI2011003577A patent/MY158406A/en unknown
- 2010-04-01 SG SG2011055332A patent/SG173487A1/en unknown
-
2011
- 2011-08-17 ZA ZA2011/06054A patent/ZA201106054B/en unknown
- 2011-09-06 CO CO11114807A patent/CO6420374A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW201039812A (en) | 2010-11-16 |
| MY158406A (en) | 2016-10-14 |
| CN102365550A (zh) | 2012-02-29 |
| PL2414838T3 (pl) | 2014-01-31 |
| EP2414838A1 (en) | 2012-02-08 |
| RU2011144028A (ru) | 2013-05-10 |
| AR076177A1 (es) | 2011-05-26 |
| US20120107843A1 (en) | 2012-05-03 |
| AU2010232590A1 (en) | 2011-08-18 |
| WO2010115031A1 (en) | 2010-10-07 |
| DK2414838T3 (da) | 2013-11-04 |
| EP2414838B1 (en) | 2013-08-28 |
| JP2012524884A (ja) | 2012-10-18 |
| CA2757317C (en) | 2014-03-11 |
| CA2757317A1 (en) | 2010-10-07 |
| HK1167272A1 (en) | 2012-11-23 |
| BRPI1013185A2 (pt) | 2016-04-12 |
| TWI405565B (zh) | 2013-08-21 |
| ZA201106054B (en) | 2014-01-29 |
| JP5330596B2 (ja) | 2013-10-30 |
| SG173487A1 (en) | 2011-09-29 |
| CN102365550B (zh) | 2014-08-13 |
| RU2524629C2 (ru) | 2014-07-27 |
| MX2011008438A (es) | 2011-09-06 |
| ES2432864T3 (es) | 2013-12-05 |
| AU2010232590B2 (en) | 2013-03-07 |
| US8637266B2 (en) | 2014-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0513897A (pt) | diferenciação de células-tronco | |
| CL2008002917A1 (es) | Anticuerpos especificos para 5-ennolpiruvilshikimato-3-fosfato sintetasa (epsps) doble mutante; hibridoma productor; método para generar dichos anticuerpos; eodo de detección de dicha enzima epsps doble mutante en una composición; kit para detectar la presencia de dicha epsps doble mutante en la composición. | |
| AR085702A1 (es) | Metodos para predecir el rendimiento en plantas y aplicaciones de uso de los mismos | |
| BRPI0713357A2 (pt) | Inibidores de proteína tirosina fosfatase humana e método de utilização. | |
| BRPI0713349A2 (pt) | Inibidores de proteína tirosina fosfatase humana e métodos de utilização | |
| BR112013002699A2 (pt) | composições inibidoras de incrustação etiquetadas e métodos para inibir incrustação | |
| CY1114303T1 (el) | Νεο οξινο θειικο αλας | |
| DOP2011000052A (es) | Metodo de identificacion de factores de riesgo de la enfermedad | |
| CY1119711T1 (el) | Νεα ενωση χρησιμη για τη θεραπεια εκφυλιστικων και φλεγμονωδων ασθενειων | |
| MX366925B (es) | Inhibidores de ibat para el tratamiento de enfermedades hepaticas. | |
| CL2008002089A1 (es) | Compuesto para la regeneracion de tejidos que comprende al menos una sustancia derivada de sangre y acido hialuronico y/o al menos un compuesto derivado de acido hialuronico; metodo para la prepararcion de dicho compuesto. | |
| MA32369B1 (fr) | Composes de benzene sulfonamide thiazole et oxazole | |
| UA118649C2 (uk) | ДВОЛАНЦЮГОВИЙ ЗАСІБ ДЛЯ PHKі ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ЕКСПРЕСІЇ ТРАНСТИРЕТИНУ (TTR) | |
| UY34701A (es) | Formas sólidas de un profármaco de nucleótidos de tiofosforamidato | |
| BRPI1003281A2 (pt) | Composição e método para maquilar um substrato queratínico | |
| FR2925826B1 (fr) | Composition inhibitrice d'urease et de nitrification | |
| GT200600346A (es) | Nueva fórmula cristalina v de la agomelatina, un proceso para su preparación y composiciones farmacéuticas que la contienen | |
| CR8879A (es) | Bifeniltiazolcarboxamidas | |
| BRPI1002771A2 (pt) | Composição e método para maquilar um substrato queratínico | |
| CR7901A (es) | Pirazolilcarboxanilidas para la lucha contra los microorganismos indeseados | |
| CR20200631A (es) | Modulares de la expresión de apol1 | |
| CO6420374A2 (es) | Efectos anti-perdida de hueso y pérdida de anti-adherimiento de una composición oral | |
| BR112014003272A2 (pt) | método e kit para o sucesso da previsão de fertilização in vitro | |
| PA8599301A1 (es) | Compuestos de benzopirano para uso en el tratamiento y la prevencion de afecciones relacionadas con la inflamacion | |
| AR058959A1 (es) | Metodos para modular receptores de la superficie celular para prevenir o reducir la inmflamacion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |